Duearity AB (publ) (DEAR.ST)
SEK 0.02
(0.0%)
SEK 0.02
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -25.76 Million SEK | -34.82% |
| 2022 | -19.16 Million SEK | -24.78% |
| 2021 | -15.35 Million SEK | -1059.21% |
| 2020 | -1.32 Million SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -4.73 Million SEK | 27.6% |
| 2024 Q1 | -6.53 Million SEK | 18.97% |
| 2023 FY | -25.83 Million SEK | -34.82% |
| 2023 Q2 | -6.22 Million SEK | -70.61% |
| 2023 Q1 | -3.65 Million SEK | 12.78% |
| 2023 Q4 | -8.06 Million SEK | -2.56% |
| 2023 Q3 | -7.86 Million SEK | -26.2% |
| 2022 Q4 | -4.18 Million SEK | -5.73% |
| 2022 FY | -19.16 Million SEK | -24.78% |
| 2022 Q1 | -5.59 Million SEK | -20.89% |
| 2022 Q3 | -3.95 Million SEK | 26.98% |
| 2022 Q2 | -5.42 Million SEK | 3.16% |
| 2021 Q3 | -3.92 Million SEK | 6.15% |
| 2021 FY | -15.35 Million SEK | -1059.21% |
| 2021 Q4 | -4.63 Million SEK | -18.09% |
| 2021 Q1 | -2.62 Million SEK | 0.0% |
| 2021 Q2 | -4.17 Million SEK | -59.08% |
| 2020 Q2 | - SEK | 0.0% |
| 2020 FY | -1.32 Million SEK | 0.0% |
| 2020 Q3 | -224 Thousand SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acarix AB (publ) | -77.55 Million SEK | 66.78% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 108.571% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 108.571% |
| Arcoma AB | 4.66 Million SEK | 652.854% |
| Bactiguard Holding AB (publ) | -131.93 Million SEK | 80.473% |
| BICO Group AB (publ) | -618.3 Million SEK | 95.833% |
| Boule Diagnostics AB (publ) | 39.27 Million SEK | 165.605% |
| CellaVision AB (publ) | 167.05 Million SEK | 115.422% |
| Clinical Laserthermia Systems AB (publ) | -65.93 Million SEK | 60.925% |
| Chordate Medical Holding AB (publ) | -29.57 Million SEK | 12.879% |
| C-Rad AB (publ) | 44.24 Million SEK | 158.229% |
| Dignitana AB (publ) | -15.02 Million SEK | -71.456% |
| Episurf Medical AB (publ) | -94.8 Million SEK | 72.824% |
| Getinge AB (publ) | 3.81 Billion SEK | 100.675% |
| Scandinavian Real Heart AB (Publ) | -68.44 Million SEK | 62.36% |
| Iconovo AB (publ) | -45.77 Million SEK | 43.72% |
| Integrum AB (publ) | 6.51 Million SEK | 495.603% |
| Luxbright AB (publ) | -25.8 Million SEK | 0.161% |
| Mentice AB (publ) | -679 Thousand SEK | -3694.256% |
| OssDsign AB (publ) | -91.95 Million SEK | 71.983% |
| Paxman AB (publ) | 12.61 Million SEK | 304.16% |
| Promimic AB (publ) | -9.11 Million SEK | -182.551% |
| Qlife Holding AB (publ) | -168.69 Million SEK | 84.728% |
| SciBase Holding AB (publ) | -53.93 Million SEK | 52.237% |
| ScandiDos AB (publ) | -13.48 Million SEK | -91.078% |
| Sectra AB (publ) | 518.49 Million SEK | 104.969% |
| Sedana Medical AB (publ) | -65.54 Million SEK | 60.695% |
| Senzime AB (publ) | -133.74 Million SEK | 80.737% |
| SpectraCure AB (publ) | -21.35 Million SEK | -20.664% |
| Stille AB | 44.95 Million SEK | 157.312% |
| Vitrolife AB (publ) | -3.58 Billion SEK | 99.282% |
| Xvivo Perfusion AB (publ) | 38.5 Million SEK | 166.906% |